This web site is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Drug Names(s): selective SMAC mimetic, TL32711
Description: TL32711 is a synthetic, small molecule peptidomimetic of SMAC (an endogenous regulator of apoptotic cell death) that selectively antagonizes multiple Inhibitor of Apoptosis Proteins (IAPs), including XIAP, cIAP-1 and cIAP-2 and ML-IAP and cause apoptotic cell death in a broad range of tumor types.
Additional information available to subscribers only: